Xcenda Report Highlights Digital Health Tech, Gene Therapies for Hemophilia
June 16, 2020
Xcenda’s latest HTA Quarterly report shifts the spotlight to digital health technology, gene therapies for hemophilia and the EU’s new guidance on digital health tech.
Below are several articles featured in the newsletter:
To read Xcenda’s summer edition of HTA Quarterly, click here.